Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during June 2025 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018'.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has submitted a routine monthly disclosure about share dematerialization for June 2025. The company confirmed that no shares were dematerialized during the month. The total number of shares held in demat form as on June 30, 2025 stood at 6,10,96,525 (approximately 6.11 crore shares), unchanged from May 31, 2025. Of these, 5,21,20,413 shares are held with NSDL and 89,76,112 shares with CDSL. The certificate was issued by the company's Registrar and Transfer Agent, Skyline Financial Services Pvt. Ltd.
This is a standard regulatory compliance filing with no material impact on the stock or shareholders. It simply reconfirms the existing demat holding pattern of the company.